Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) EPS (Weighted Average and Diluted) (2021 - 2022)

Catheter Precision (VTAK) has disclosed EPS (Weighted Average and Diluted) for 2 consecutive years, with $2.02 as the latest value for Q4 2022.

  • Quarterly EPS (Weighted Average and Diluted) rose 103.42% to $2.02 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$95.01 through Dec 2022, down 279.59% year-over-year, with the annual reading at -$25.98 for FY2022, 90.37% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2022 was $2.02 at Catheter Precision, up from -$4.36 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $2.02 in Q4 2022, with the low at -$59.09 in Q4 2021.